Sangam Health Care Products
In the Jun 2026 quarter, revenue rose 7.5% year on year to ₹3.03 Cr and net profit was ₹0.31 Cr, against ₹0.10 Cr a year earlier (compared with Jun 2025). Promoters held 70.12% of Sangam Health Care Products in Jun 2026, unchanged from Mar 2026.
Peer Comparison
Healthcare › Healthcare Equipment & Supplies › Medical Equipment & Supplies
| ₹1,463.20 | 47.06 | 14,831 Cr | 4.77 | 0.24% | 10.18% | 13.33% | 2,115 Cr | 313 Cr | |
| ₹26.13 | 68.76 | 1,710 Cr | 3.74 | 0.20% | 8.11% | 12.69% | 373 Cr | 24 Cr | |
| ₹308.20 | 147.46 | 1,640 Cr | 2.58 | 0.66% | 2.26% | 4.82% | 468 Cr | 11 Cr | |
| ₹550.00 | 26.07 | 1,283 Cr | 2.63 | 0.00% | 22.63% | 26.37% | 201 Cr | 34 Cr | |
| ₹178.59 | 31.83 | 983 Cr | 4.04 | 0.00% | 10.83% | 11.51% | 289 Cr | 31 Cr | |
| — | — | 832 Cr | 5.31 | 0.00% | 13.22% | 19.52% | — | — | |
Sangam Health Care Products (this company) | — | — | — | — | — | — | — | 12 Cr | 0 Cr |
| Median 7 companies | ₹308.20 | 47.06 | 1,461 Cr | 3.89 | 0.10% | 10.51% | 13.01% | 331 Cr | 28 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 2 companies are not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
2- The company has delivered a poor sales growth of 3.32% over past five years.
- Debtor days have increased from 76.2 to 114 days.
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.56 | 3.05 | 3.53 | 2.97 | 3.39 | 3.62 | 2.87 | 2.58 | 2.82 | 3.04 | 2.72 | 2.66 | 3.03 |
| Expenses | 2.94 | 2.54 | 2.66 | 2.79 | 3 | 3.24 | 2.46 | 2.29 | 2.7 | 2.74 | 2.42 | 3.14 | 2.59 |
| Operating Profit | -0.38 | 0.51 | 0.87 | 0.18 | 0.39 | 0.38 | 0.41 | 0.29 | 0.12 | 0.3 | 0.3 | -0.48 | 0.44 |
| OPM % | -14.84% | 16.72% | 24.65% | 6.06% | 11.5% | 10.5% | 14.29% | 11.24% | 4.26% | 9.87% | 11.03% | -18.05% | 14.52% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.02 | 0 |
| Interest | 0.01 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.3 | 0.3 | 0.3 | 0.31 | 0.3 | 0.3 | 0.3 | 0.31 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| PBT | -0.69 | 0.21 | 0.56 | -0.14 | 0.09 | 0.08 | 0.11 | -0.01 | 0.11 | 0.29 | 0.29 | -0.48 | 0.43 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -1900% | 9.09% | 17.24% | 34.48% | -39.58% | 27.91% |
| Net Profit | -0.69 | 0.2 | 0.56 | -0.14 | 0.08 | 0.07 | 0.11 | 0.19 | 0.1 | 0.23 | 0.2 | -0.28 | 0.31 |
| EPS (₹) | -0.46 | 0.13 | 0.38 | -0.09 | 0.05 | 0.05 | 0.07 | 0.13 | 0.07 | 0.15 | 0.13 | -0.19 | 0.21 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.44 | 23.71 | 24.16 | 20.99 | 21.04 | 21.81 | 9.54 | 8.7 | 10.76 | 12.11 | 12.46 | 11.23 | 11.45 |
| Expenses | 21.43 | 20.19 | 24.55 | 25.62 | 20.09 | 19.78 | 10.86 | 9.1 | 10.88 | 10.67 | 11 | 10.98 | 10.89 |
| Operating Profit | 4.01 | 3.52 | -0.39 | -4.63 | 0.95 | 2.03 | -1.32 | -0.4 | -0.12 | 1.44 | 1.46 | 0.25 | 0.56 |
| OPM % | 15.76% | 14.85% | -1.61% | -22.06% | 4.52% | 9.31% | -13.84% | -4.6% | -1.12% | 11.89% | 11.72% | 2.23% | 4.89% |
| Other Income | 4.75 | 0.27 | 0.12 | 18.41 | 0.47 | 2.93 | 0.02 | 0 | 0 | 0 | 0.02 | 0.02 | 0.02 |
| Interest | 5.46 | 3.8 | 5.05 | 3.33 | 2.1 | 0.29 | 0.07 | 0.11 | 0.03 | 0.02 | 0.01 | 0.01 | 0 |
| Depreciation | 1.51 | 1.53 | 1.52 | 1.52 | 1.5 | 1.26 | 1.22 | 1.22 | 1.22 | 1.22 | 1.22 | 0.06 | 0.05 |
| PBT | 1.79 | -1.54 | -6.84 | 8.93 | -2.18 | 3.41 | -2.59 | -1.73 | -1.37 | 0.2 | 0.25 | 0.2 | 0.53 |
| Tax % | 0% | 0% | 0.29% | 17.36% | -6.88% | -18.77% | -11.2% | -10.4% | -14.6% | -110% | -76% | 75% | — |
| Net Profit | 1.79 | -1.54 | -6.86 | 7.37 | -2.03 | 4.05 | -2.3 | -1.55 | -1.16 | 0.42 | 0.45 | 0.05 | 0.46 |
| EPS (₹) | 1.2 | -1.04 | -4.62 | 4.96 | -1.37 | 2.73 | -1.55 | -1.04 | -0.78 | 0.28 | 0.3 | 0.03 | 0.3 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 |
| Reserves | -31.81 | -33.35 | -37.85 | -28.59 | -34.83 | -30.78 | -33.08 | -34.63 | -35.79 | -35.37 | -34.92 | -34.71 |
| Borrowings | 35.37 | 36.08 | 37.27 | 17.25 | 21.15 | 17.59 | 18.21 | 23.4 | 21.08 | 19.34 | 21.98 | 21.93 |
| Other Liabilities | 14.15 | 15.13 | 13.65 | 18.66 | 22.59 | 11.29 | 9.43 | 5.46 | 7.92 | 7.67 | 9.42 | 9.14 |
| Total Liabilities | 32.57 | 32.72 | 27.93 | 22.18 | 23.77 | 12.96 | 9.42 | 9.09 | 8.07 | 6.5 | 11.34 | 11.22 |
| Fixed Assets | 23.94 | 22.63 | 21.44 | 19.93 | 18.65 | 6.24 | 5.02 | 3.81 | 2.61 | 1.39 | 0.18 | 0.3 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8.63 | 10.09 | 6.49 | 2.25 | 5.12 | 6.72 | 4.4 | 5.28 | 5.46 | 5.11 | 11.16 | 10.92 |
| Total Assets | 32.57 | 32.72 | 27.93 | 22.18 | 23.77 | 12.96 | 9.42 | 9.09 | 8.07 | 6.5 | 11.34 | 11.22 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -16.8 | -0.37 | -4.44 | -5.97 | 11.05 | -11.08 | 0.14 | 0.99 | 2.49 | 1.94 | -2.76 | 0.03 |
| Investing | 4.71 | -0.21 | -0.29 | 18.7 | -1.02 | 11.18 | 0.02 | 0.02 | 0 | 0 | 0 | -0.02 |
| Financing | 12.22 | 2.07 | 3.13 | -12.72 | -10.15 | -0.02 | -0.13 | -0.13 | -2.35 | -1.77 | 2.63 | -0.06 |
| Net Cash Flow | 0.13 | 1.48 | -1.6 | 0.01 | -0.12 | 0.07 | 0.03 | 0.88 | 0.14 | 0.18 | -0.13 | -0.06 |
| Free Cash Flow | -16.84 | -0.58 | -4.78 | -5.98 | 10.82 | 0.08 | 0.14 | 0.99 | 2.49 | 1.94 | -2.76 | 0.03 |
| CFO/OP | -419 | -11 | 1,138 | 129 | 1,171 | -546 | -11 | -248 | -2,075 | 135 | -189 | 12 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3.73 | 2 | 0.91 | 0.17 | 6.07 | 8.37 | 26.4 | 25.59 | 21.37 | 8.14 | 106 | 114 |
| Inventory Days | 327 | 257 | 136 | 21.81 | 107 | 137 | 68.48 | 133 | 162 | 101 | 90.56 | 78.77 |
| Days Payable | 259 | 286 | 156 | 127 | 155 | 219 | 285 | 191 | 384 | 359 | 455 | 480 |
| Cash Conversion Cycle | 71.32 | -26.94 | -19.07 | -106 | -41.64 | -73.53 | -190 | -32.73 | -201 | -250 | -258 | -286 |
| Working Capital Days | -225 | -240 | -254 | -339 | -628 | -346 | -880 | -981 | -107 | -110 | -77.92 | -75.41 |
| ROCE % | 37.12% | 12.55% | -11.23% | 137.75% | -3.4% | 259.65% | -303.61% | -89.5% | -70.9% | — | 69.33% | 10.5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sangam Health Care Products insights
29 extracted metrics + investor summaries across FY15–FY27.
Documents
Frequently Asked Questions about Sangam Health Care Products
What does Sangam Health Care Products Ltd do?
Where is Sangam Health Care Products Ltd (SANHP) listed?
Which sector does Sangam Health Care Products Ltd belong to?
Company Information
Sangam Health Care Products is engaged manufacturing and trading of medical products
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/1269907.md for Sangam Health Care Products Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.